Package 16714-549-01

Brand: lacosamide

Generic: lacosamide
NDC Package

Package Facts

Identity

Package NDC 16714-549-01
Digits Only 1671454901
Product NDC 16714-549
Description

60 TABLET in 1 BOTTLE (16714-549-01)

Marketing

Marketing Status
Marketed Since 2022-08-01
Brand lacosamide
Generic lacosamide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ad8753cb-70b7-431e-9d52-93558d469ef5", "openfda": {"nui": ["N0000008486"], "upc": ["0316714548012", "0316714550015", "0316714552019", "0316714549019"], "unii": ["563KS2PQY5"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_set_id": ["9dffda6c-9e44-478f-9e02-9da3ab4c50e1"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (16714-549-01)", "package_ndc": "16714-549-01", "marketing_start_date": "20220801"}], "brand_name": "Lacosamide", "product_id": "16714-549_ad8753cb-70b7-431e-9d52-93558d469ef5", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "16714-549", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "100 mg/1"}], "application_number": "ANDA208308", "marketing_category": "ANDA", "marketing_start_date": "20220801", "listing_expiration_date": "20261231"}